Ascending multiple-dose pharmacokinetics of viramidine, a prodrug of ribavirin, in adult subjects with compensated hepatitis C infection.
about
Randomised clinical trial: pre-dosing with taribavirin before starting pegylated interferon vs. standard combination regimen in treatment-naïve patients with chronic hepatitis C genotype 1.Established and emerging therapies for the treatment of viral hepatitis.Small molecule and novel treatments for chronic hepatitis C virus infection.Taribavirin in the treatment of hepatitis C.Absorption, metabolism, and excretion of [14C]viramidine in humans.
P2860
Ascending multiple-dose pharmacokinetics of viramidine, a prodrug of ribavirin, in adult subjects with compensated hepatitis C infection.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh-hant
name
Ascending multiple-dose pharma ...... ensated hepatitis C infection.
@en
Ascending multiple-dose pharma ...... ensated hepatitis C infection.
@nl
type
label
Ascending multiple-dose pharma ...... ensated hepatitis C infection.
@en
Ascending multiple-dose pharma ...... ensated hepatitis C infection.
@nl
prefLabel
Ascending multiple-dose pharma ...... ensated hepatitis C infection.
@en
Ascending multiple-dose pharma ...... ensated hepatitis C infection.
@nl
P2093
P2860
P356
P1476
Ascending multiple-dose pharma ...... ensated hepatitis C infection.
@en
P2093
Alice Teng
Chin-chung Lin
Christine Xu
Janet Peterson
Li-Tain Yeh
Sanjee Aora
Stephen Rossi
P2860
P304
P356
10.1177/0091270004270152
P50
P577
2005-03-01T00:00:00Z